Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Shares, Euro 0.09 nominal value per share
-
Shares outstanding
-
75,893,250
-
Total 13F shares
-
22,159,049
-
Share change
-
-4,618,940
-
Total reported value
-
$487,625,074
-
Price per share
-
$22.00
-
Number of holders
-
62
-
Value change
-
-$93,777,235
-
Number of buys
-
28
-
Number of sells
-
34
Institutional Holders of Merus N.V. - Common Shares, Euro 0.09 nominal value per share (MRUS) as of Q3 2021
As of 30 Sep 2021,
Merus N.V. - Common Shares, Euro 0.09 nominal value per share (MRUS) was held by
62 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
22,159,049 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, FEDERATED HERMES, INC., BAKER BROS. ADVISORS LP, BOXER CAPITAL, LLC, Medicxi Ventures Management (Jersey) Ltd, BioImpact Capital LLC, COMMODORE CAPITAL LP, DRIEHAUS CAPITAL MANAGEMENT LLC, MILLENNIUM MANAGEMENT LLC, and Avoro Capital Advisors LLC.
This page lists
63
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.